A.QuastD
The foundational characterisation comes from Raun et al., 1998, who described ipamorelin as "the first selective growth hormone secretagogue." In the taxonomy of research peptides, ipamorelin therefore sits between the older, less selective compounds such as GHRP-2 and GHRP-6 on one side and the GHRH analogues such as CJC-1295 or tesamorelin on the other
Trans-nuclei CRISPR/Cas9: safe approach for genome editing in the edible mushroom excluding foreign DNA sequences
Others warn that anecdotal benefits may overshadow the reality that individual results vary and that no supplement, botanical or otherwise, can be a substitute for medical intervention when needed
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited
Rodent studies: Three preclinical studies investigated the effects of amino acid supplementation on ES-induced behavioral deficits